Afuco™ Anti-Human MIEN1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-MIEN1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-C35 antibodies are used for treatment for C35-positive cancers comprising testing for the expression of receptor molecules such as HER2, EGFR, and IGFR.
Supplier Creative Biolabs
Product # AFC-507CL
Pricing Inquiry
Host Human
Target MIEN1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback